Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Seres Therapeutics, Inc. | mcrb-ex321_8.htm |
| EX-31.1 - EX-31.1 - Seres Therapeutics, Inc. | mcrb-ex311_7.htm |
| EX-31.2 - EX-31.2 - Seres Therapeutics, Inc. | mcrb-ex312_9.htm |
| EX-32.2 - EX-32.2 - Seres Therapeutics, Inc. | mcrb-ex322_171.htm |
| EX-10.13 - EX-10.13 - Seres Therapeutics, Inc. | mcrb-ex1013_656.htm |
| 10-K - 10-K - Seres Therapeutics, Inc. | mcrb-10k_20151231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-205253) of Seres Therapeutics, Inc. of our report dated March 14, 2016 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 14, 2016